MOTS-C (Mitochondrial Open Reading Frame of the Twelve S rRNA Type-C) is a sixteen-amino-acid peptide encoded by the mitochondrial genome. Its discovery in 2015 by Changhan David Lee and colleagues at the University of Southern California opened a new chapter in metabolic research — it was among the first peptides shown to be encoded by mitochondrial DNA rather than nuclear DNA, challenging longstanding assumptions about where bioactive signaling molecules originate.
Why Mitochondrial Origin Matters
Most bioactive peptides are encoded in nuclear DNA, transcribed in the nucleus, translated by cytoplasmic ribosomes, and then processed and secreted through the endoplasmic reticulum and Golgi apparatus. MOTS-C breaks this paradigm. It is encoded within the 12S ribosomal RNA gene of the mitochondrial genome and appears to act as a retrograde signal from the mitochondria to the nucleus — a form of inter-organelle communication.
This mitochondrial origin means MOTS-C is maternally inherited (mitochondrial DNA passes exclusively through the maternal line in mammals) and is subject to mitochondrial genetic variation across populations. Researchers have identified polymorphisms in the MOTS-C coding region that correlate with metabolic phenotypes in population studies, suggesting the peptide may play a role in inherited metabolic tendencies.
Observed Effects in Preclinical Models
The initial 2015 Cell Metabolism publication demonstrated that MOTS-C treatment in obese mice improved glucose tolerance, reduced fat mass, and increased insulin sensitivity. Subsequent studies have expanded the scope to include exercise mimetic effects — MOTS-C treated animals showed improved physical performance and skeletal muscle metabolism without changes in activity level.
A particularly striking finding came from cold exposure studies. Researchers demonstrated that MOTS-C levels increase in response to cold stress and exercise in both mice and humans, suggesting the peptide functions as a stress-responsive metabolic signal rather than a static housekeeping molecule.
In cellular models, MOTS-C activates the AMPK pathway (AMP-activated protein kinase), a master regulator of cellular energy homeostasis. It also influences folate metabolism and the methionine cycle, linking it to one-carbon metabolism — a fundamental biochemical network involved in DNA methylation, nucleotide synthesis, and redox balance.
Handling and Storage
MOTS-C is supplied as a lyophilized powder and should be stored at negative twenty degrees Celsius. Reconstitute with bacteriostatic water and use reconstituted solutions within three to four weeks when stored at two to eight degrees Celsius. The peptide is relatively hydrophilic and dissolves readily in aqueous solutions. Avoid repeated freeze-thaw cycles — aliquot reconstituted material if multiple uses are planned.
Purity Standards
Given the small size of the peptide (sixteen residues, molecular weight approximately two thousand one hundred seventy daltons), synthesis is straightforward and high purity is achievable. Research-grade MOTS-C should be ninety-eight percent or higher by HPLC with mass spectrometry identity confirmation. At Universal Amino Goods, we provide third-party certificates of analysis with every order.
Current Research Landscape
MOTS-C research has accelerated rapidly since 2015, with publications exploring its role in aging, diabetes, obesity, exercise physiology, and cancer biology. A 2023 review in Nature Reviews Endocrinology highlighted the peptide as one of the most promising mitochondrial-derived peptides for future metabolic research. No human clinical trials have been completed, but the mechanistic data and animal model results have generated significant interest across multiple fields.
For metabolic researchers looking to explore mitochondrial signaling, AMPK activation, or exercise mimetic compounds, MOTS-C offers a well-characterized starting point backed by a growing body of high-quality preclinical literature.